A woman has taken to the internet to share the biggest difference she experienced when switching between GLP-1 drugs Wegovy ...

GLP-1 drugs, synthetic versions of a natural hormone, are revolutionizing weight loss and type 2 diabetes treatment. By ...

Explore how GLP-1 drugs like Ozempic, Wegovy, and Mounjaro are impacting obesity rates in America, while also highlighting ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

An expert said weight loss drugs might help people see faster results, which can give them encouragement to continue. But he ...

Lilly tops Q3 estimates as Mounjaro and Zepbound fuel a 54% revenue surge, prompting the drugmaker to raise its full-year ...

Amy Schumer unveiled her slimmer figure after losing about 40lbs, crediting the weight-loss drug Mounjaro for her ...

Eli Lilly’s blockbuster drug Mounjaro has quickly become the market leader in the segment, thanks to its strong clinical performance and early entry advantage.

The government is pushing to designate Wegovy and Mounjaro, among other new obesity treatments, as “medicines of concern for ...

Worth noting, CVS Caremark—the biggest PBM in the U.S.— announced in May that it would make Novo Nordisk’s rival drug Wegovy ...

Novo Nordisk's late bid to hijack Pfizer's takeover of U.S. obesity biotech Metsera marks an aggressive shift from the Danish ...